These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 21467790)

  • 21. Antiplatelet regimens in the long-term secondary prevention of transient ischaemic attack and ischaemic stroke: an updated network meta-analysis.
    Niu PP; Guo ZN; Jin H; Xing YQ; Yang Y
    BMJ Open; 2016 Mar; 6(3):e009013. PubMed ID: 26988347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiplatelet cilostazol is effective in the prevention of pneumonia in ischemic stroke patients in the chronic stage.
    Shinohara Y
    Cerebrovasc Dis; 2006; 22(1):57-60. PubMed ID: 16645267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cilostazol in the management of atherosclerosis.
    Sallustio F; Rotondo F; Di Legge S; Stanzione P
    Curr Vasc Pharmacol; 2010 May; 8(3):363-72. PubMed ID: 20180773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiplatelet Agents for the Secondary Prevention of Ischemic Stroke or Transient Ischemic Attack: A Network Meta-Analysis.
    Wang W; Zhang L; Liu W; Zhu Q; Lan Q; Zhao J
    J Stroke Cerebrovasc Dis; 2016 May; 25(5):1081-1089. PubMed ID: 26856461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phosphodiesterase-III inhibitor prevents hemorrhagic transformation induced by focal cerebral ischemia in mice treated with tPA.
    Ishiguro M; Mishiro K; Fujiwara Y; Chen H; Izuta H; Tsuruma K; Shimazawa M; Yoshimura S; Satoh M; Iwama T; Hara H
    PLoS One; 2010 Dec; 5(12):e15178. PubMed ID: 21151895
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cilostazol attenuates gray and white matter damage in a rodent model of focal cerebral ischemia.
    Honda F; Imai H; Ishikawa M; Kubota C; Shimizu T; Fukunaga M; Saito N
    Stroke; 2006 Jan; 37(1):223-8. PubMed ID: 16339464
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of cilostazol and aspirin pre-treatment against subsequent transient focal cerebral ischemia in rat.
    Toda Y; Katsura K; Saito M; Inaba T; Sakurazawa M; Katayama Y
    Neurol Res; 2014 Nov; 36(11):1011-9. PubMed ID: 24836463
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platelet inhibition by adjunctive cilostazol suppresses the frequency of cerebral ischemic lesions after carotid artery stenting in patients with carotid artery stenosis.
    Nakagawa I; Wada T; Park HS; Nishimura F; Yamada S; Nakagawa H; Kichikawa K; Nakase H
    J Vasc Surg; 2014 Mar; 59(3):761-7. PubMed ID: 24239116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Poly(ADP-ribose) polymerase inhibition by cilostazol is implicated in the neuroprotective effect against focal cerebral ischemic infarct in rat.
    Lee JH; Park SY; Shin HK; Kim CD; Lee WS; Hong KW
    Brain Res; 2007 Jun; 1152():182-90. PubMed ID: 17433265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cilostazol as an alternative to aspirin after ischaemic stroke: a randomised, double-blind, pilot study.
    Huang Y; Cheng Y; Wu J; Li Y; Xu E; Hong Z; Li Z; Zhang W; Ding M; Gao X; Fan D; Zeng J; Wong K; Lu C; Xiao J; Yao C;
    Lancet Neurol; 2008 Jun; 7(6):494-9. PubMed ID: 18456558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroprotective effect of cilostazol against retinal ischemic damage via inhibition of leukocyte-endothelial cell interactions.
    Iwama D; Miyamoto K; Miyahara S; Tamura H; Tsujikawa A; Yamashiro K; Kiryu J; Yoshimura N
    J Thromb Haemost; 2007 Apr; 5(4):818-25. PubMed ID: 17408412
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Benefit of cilostazol in patients with high risk of bleeding: subanalysis of cilostazol stroke prevention study 2.
    Uchiyama S; Shinohara Y; Katayama Y; Yamaguchi T; Handa S; Matsuoka K; Ohashi Y; Tanahashi N; Yamamoto H; Genka C; Kitagawa Y; Kusuoka H; Nishimaru K; Tsushima M; Koretsune Y; Sawada T; Hamada C
    Cerebrovasc Dis; 2014; 37(4):296-303. PubMed ID: 24820203
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiplatelet cilostazol is beneficial in diabetic and/or hypertensive ischemic stroke patients. Subgroup analysis of the cilostazol stroke prevention study.
    Shinohara Y; Gotoh F; Tohgi H; Hirai S; Terashi A; Fukuuchi Y; Otomo E; Itoh E; Matsuda T; Sawada T; Yamaguchi T; Nishimaru K; Ohashi Y
    Cerebrovasc Dis; 2008; 26(1):63-70. PubMed ID: 18511873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cilostazol protects mice against endotoxin shock and attenuates LPS-induced cytokine expression in RAW 264.7 macrophages via MAPK inhibition and NF-kappaB inactivation: not involved in cAMP mechanisms.
    Park WS; Jung WK; Lee DY; Moon C; Yea SS; Park SG; Seo SK; Park C; Choi YH; Kim GY; Choi JS; Choi IW
    Int Immunopharmacol; 2010 Sep; 10(9):1077-85. PubMed ID: 20601185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cilostazol, a phosphodiesterase inhibitor, attenuates photothrombotic focal ischemic brain injury in hypertensive rats.
    Ito H; Hashimoto A; Matsumoto Y; Yao H; Miyakoda G
    J Cereb Blood Flow Metab; 2010 Feb; 30(2):343-51. PubMed ID: 19809463
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The efficacy and safety of cilostazol for the secondary prevention of ischemic stroke in acute and chronic phases in Asian population--an updated meta-analysis.
    Shi L; Pu J; Xu L; Malaguit J; Zhang J; Chen S
    BMC Neurol; 2014 Dec; 14():251. PubMed ID: 25527141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-depressant effects of phosphodiesterase 3 inhibitor cilostazol in chronic mild stress-treated mice after ischemic stroke.
    Kim YR; Kim HN; Hong KW; Shin HK; Choi BT
    Psychopharmacology (Berl); 2016 Mar; 233(6):1055-66. PubMed ID: 26686236
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cilostazol, an inhibitor of type 3 phosphodiesterase, produces endothelium-independent vasodilation in pressurized rabbit cerebral penetrating arterioles.
    Nakamura K; Ikomi F; Ohhashi T
    J Vasc Res; 2006; 43(1):86-94. PubMed ID: 16286783
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cilostazol inhibits cytokine-induced nuclear factor-kappaB activation via AMP-activated protein kinase activation in vascular endothelial cells.
    Hattori Y; Suzuki K; Tomizawa A; Hirama N; Okayasu T; Hattori S; Satoh H; Akimoto K; Kasai K
    Cardiovasc Res; 2009 Jan; 81(1):133-9. PubMed ID: 18703532
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination treatment with normobaric hyperoxia and cilostazol protects mice against focal cerebral ischemia-induced neuronal damage better than each treatment alone.
    Nonaka Y; Koumura A; Hyakkoku K; Shimazawa M; Yoshimura S; Iwama T; Hara H
    J Pharmacol Exp Ther; 2009 Jul; 330(1):13-22. PubMed ID: 19336663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.